vs
Side-by-side financial comparison of NewAmsterdam Pharma Co N.V. (NAMS) and Snail, Inc. (SNAL). Click either name above to swap in a different company.
Snail, Inc. is the larger business by last-quarter revenue ($25.1M vs $19.1M, roughly 1.3× NewAmsterdam Pharma Co N.V.). Snail, Inc. runs the higher net margin — -3.4% vs -90.7%, a 87.3% gap on every dollar of revenue. On growth, NewAmsterdam Pharma Co N.V. posted the faster year-over-year revenue change (740.1% vs -4.2%).
Kite Pharma, Inc. is an American biotechnology company that develops cancer immunotherapy products with a primary focus on genetically engineered autologous CAR T cell therapy - a cell-based therapy which relies on chimeric antigen receptors and T cells. Founded in 2009, and based in Santa Monica, California, it was acquired by Gilead Sciences in 2017.
Suzhou Snail Digital Technology Co., Ltd., doing business as Snail, is a Chinese video game company and a Virtual Network Operator headquartered in Suzhou, China, which has branches Snail Games and Snail Mobile. Its division, Snail USA, markets Snail Games products in North America, South America, & Europe. Snail Games products include massively multiplayer online (MMOs), real-time strategy (RTS), and casual games. Its global registered user base has reached over 70 million accounts. The U.S....
NAMS vs SNAL — Head-to-Head
Income Statement — Q2 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $19.1M | $25.1M |
| Net Profit | $-17.4M | $-862.2K |
| Gross Margin | — | 38.3% |
| Operating Margin | -186.1% | -6.0% |
| Net Margin | -90.7% | -3.4% |
| Revenue YoY | 740.1% | -4.2% |
| Net Profit YoY | 55.5% | -177.0% |
| EPS (diluted) | $-0.15 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $25.1M | ||
| Q3 25 | — | $13.8M | ||
| Q2 25 | $19.1M | $22.2M | ||
| Q1 25 | — | $20.1M | ||
| Q4 24 | $12.8M | $26.2M | ||
| Q3 24 | $29.1M | $22.5M | ||
| Q2 24 | — | $21.6M | ||
| Q1 24 | — | $14.1M |
| Q4 25 | — | $-862.2K | ||
| Q3 25 | — | $-7.9M | ||
| Q2 25 | $-17.4M | $-16.6M | ||
| Q1 25 | — | $-1.9M | ||
| Q4 24 | $-92.2M | $1.1M | ||
| Q3 24 | $-16.6M | $235.1K | ||
| Q2 24 | — | $2.3M | ||
| Q1 24 | — | $-1.8M |
| Q4 25 | — | 38.3% | ||
| Q3 25 | — | 0.1% | ||
| Q2 25 | — | 31.3% | ||
| Q1 25 | — | 29.1% | ||
| Q4 24 | — | 43.3% | ||
| Q3 24 | — | 38.6% | ||
| Q2 24 | — | 37.5% | ||
| Q1 24 | — | 14.7% |
| Q4 25 | — | -6.0% | ||
| Q3 25 | — | -71.3% | ||
| Q2 25 | -186.1% | -8.2% | ||
| Q1 25 | — | -20.4% | ||
| Q4 24 | -338.5% | 11.5% | ||
| Q3 24 | -85.9% | 1.8% | ||
| Q2 24 | — | 12.4% | ||
| Q1 24 | — | -15.6% |
| Q4 25 | — | -3.4% | ||
| Q3 25 | — | -56.9% | ||
| Q2 25 | -90.7% | -74.7% | ||
| Q1 25 | — | -9.7% | ||
| Q4 24 | -721.7% | 4.3% | ||
| Q3 24 | -57.2% | 1.0% | ||
| Q2 24 | — | 10.4% | ||
| Q1 24 | — | -12.6% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $-0.15 | $-0.44 | ||
| Q1 25 | — | $-0.06 | ||
| Q4 24 | $-0.91 | $0.03 | ||
| Q3 24 | $-0.18 | $0.01 | ||
| Q2 24 | — | $0.06 | ||
| Q1 24 | — | $-0.05 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $739.2M | $8.6M |
| Total DebtLower is stronger | — | $14.6M |
| Stockholders' EquityBook value | $778.5M | $-16.4M |
| Total Assets | $815.1M | $59.3M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $8.6M | ||
| Q3 25 | — | $12.3M | ||
| Q2 25 | $739.2M | $7.9M | ||
| Q1 25 | — | $9.4M | ||
| Q4 24 | $834.2M | $7.3M | ||
| Q3 24 | $422.7M | $10.6M | ||
| Q2 24 | — | $15.5M | ||
| Q1 24 | — | $16.1M |
| Q4 25 | — | $14.6M | ||
| Q3 25 | — | $10.5M | ||
| Q2 25 | — | $11.8M | ||
| Q1 25 | — | $9.0M | ||
| Q4 24 | — | $5.7M | ||
| Q3 24 | — | $5.7M | ||
| Q2 24 | — | $5.8M | ||
| Q1 24 | — | $6.5M |
| Q4 25 | — | $-16.4M | ||
| Q3 25 | — | $-15.6M | ||
| Q2 25 | $778.5M | $-8.0M | ||
| Q1 25 | — | $9.1M | ||
| Q4 24 | $757.5M | $9.7M | ||
| Q3 24 | $378.9M | $8.2M | ||
| Q2 24 | — | $7.9M | ||
| Q1 24 | — | $5.6M |
| Q4 25 | — | $59.3M | ||
| Q3 25 | — | $51.1M | ||
| Q2 25 | $815.1M | $58.0M | ||
| Q1 25 | — | $64.5M | ||
| Q4 24 | $864.6M | $62.2M | ||
| Q3 24 | $439.2M | $66.8M | ||
| Q2 24 | — | $75.4M | ||
| Q1 24 | — | $78.3M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 0.99× | ||
| Q4 24 | — | 0.59× | ||
| Q3 24 | — | 0.70× | ||
| Q2 24 | — | 0.73× | ||
| Q1 24 | — | 1.16× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-37.7M | $-5.3M |
| Free Cash FlowOCF − Capex | $-37.8M | — |
| FCF MarginFCF / Revenue | -197.2% | — |
| Capex IntensityCapex / Revenue | 0.5% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-119.7M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $-5.3M | ||
| Q3 25 | — | $6.6M | ||
| Q2 25 | $-37.7M | $-3.2M | ||
| Q1 25 | — | $764.5K | ||
| Q4 24 | $-37.5M | $-3.6M | ||
| Q3 24 | $-12.5M | $-5.0M | ||
| Q2 24 | — | $206.6K | ||
| Q1 24 | — | $6.8M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $-37.8M | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $-37.5M | — | ||
| Q3 24 | $-12.6M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | -197.2% | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -293.5% | — | ||
| Q3 24 | -43.2% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 0.5% | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.0% | — | ||
| Q3 24 | 0.3% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | -3.21× | ||
| Q3 24 | — | -21.05× | ||
| Q2 24 | — | 0.09× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
NAMS
Segment breakdown not available.
SNAL
| Pc | $14.7M | 59% |
| Platform Three | $5.2M | 21% |
| Platform Two | $3.3M | 13% |
| Sales Channel Directly To Consumer Mobile Sale | $1.6M | 6% |
